PsA Treatment With hOKT3γ1 (Ala-Ala)

Stopped Study team decision-impact(s) of change in hOKT3γ1 (Ala-Ala) manufacturer during study.

Conditions

• Arthritis, Psoriatic

Interventions

• DRUG: hOKT3gamma1(Ala-Ala)
• DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

• [object Object]